Comparisons of multiple characteristics between young and old lung cancer patients

Chinese Medical Journal

Volumn 125, Issue 1, 2012, Pages 72-80

  Jiang, Wei ^a,c   Kang, Yue ^b   Shi, Guang Yue ^a   Zhang, Hai Yu ^a   Cai, Li ^a   Sun, Xiu Wei ^a   Sun, Li Chun ^a   Sui, Guang Jie ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^c HARBIN ENGINEERING UNIVERSITY   (China)

Author keywords

Age factor; Epidemiology; Lung neoplasm; Prognosis; Survival analysis

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SEX RATIO; SMOKING; SURVIVAL RATE; SURVIVAL TIME; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SMOKING; SURVIVAL RATE; YOUNG ADULT;

EID: 84862924335     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.01.014     Document Type: Article

References (72)

1. Boulikas T, Stathopoulos GP, Volakakis N, Vougiouka M. Systemic lipoplatin infusion results in preferential tumor uptake in human studies. Anticancer Res 2005; 25: 3031-3039.
2. Schofield P, Ugalde A, Carey M, Mileshkin L, Duffy M, Ball D, et al. Lung cancer: Challenges and solutions for supportive care intervention research. Palliat Support Care 2008; 6: 281-287.
3. Khuri FR, Herbst RS, Fossella FV. Emerging therapies in non-small-cell lung cancer. Ann Oncol 2001; 12: 739-744.
4. Wimmer-Puchinger B. Women's health in Austria. Zentralbl Gynakol 2005; 127: 333-337.
5. Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004; 101: 3-27.
6. Merrill RM, Weed DL. Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates. Ann Epidemiol 2001; 11: 547-553.
7. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997; 47: 5-27.
8. Alberg AJ, Ford JG, Samet JM. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132 (3 Suppl): 29S-55S.
9. Lam TH, Ho SY, Hedley AJ, Mak KH, Peto R. Mortality and smoking in Hong Kong: Case-control study of all adult deaths in 1998. BMJ 2001; 323: 361.
10. Liu NS, Spitz MR, Kemp BL, Cooksley C, Fossella FV, Lee JS, et al. Adenocarcinoma of the lung in young patients: Them. D. Anderson experience. Cancer 2000; 88: 1837-1841.
11. Prasad R, Verma SK. Comparison between young and old patients with bronchogenic carcinoma. J Cancer Res Ther 2009; 5: 31-35.
12. Elci OC, Akpinar-Elci M. The trend of small cell lung cancer among young men. Lung Cancer 2007; 57: 34-36.
13. Kocak Z, Uzal MC, Uygun K. Rising lung cancer deaths among younger individuals: Lung carcinoma in a patient at the age of 26. Onkologie 2004; 27: 212.
14. Mzushima Y, Yokoyama A, Ito M, Manabe H, Hirai T, Minami H, et al. Lung carcinoma in patients age younger than 30 years. Cancer 1999; 85: 1730-1733.
15. Whooley BP, Urschel JD, Antkowiak JG, Takita H. Bronchogenic carcinoma in patients age 30 and younger. Ann Thorac Cardiovasc Surg 2000; 6: 86-88.
16. Skarin AT, Herbst RS, Leong TL, Bailey A, Sugarbaker D. Lung cancer in patients under age 40. Lung Cancer 2001; 32: 255-264.
17. Bryant AS, Cerfolio RJ. Differences in outcomes between younger and older patients with non-small cell lung cancer. Ann Thorac Surg 2008; 85: 1735-1739; discussion 1739.
18. Maruyama R, Yoshino I, Yohena T, Uehara T, Kanematsu T, Kitajima M, et al. Lung cancer in patients younger than 40 years of age. J Surg Oncol 2001; 77: 208-212.
19. Yazgan S, Gursoy S, Yaldiz S, Basok O Outcome of surgery for lung cancer in young and elderly patients. Surg Today 2005; 35: 823-827.
20. Radzikowska E, Roszkowski K, Glaz P. Lung cancer in patients under 50 years old. Lung Cancer 2001; 33: 203-211.
21. Tian DL, Liu HX, Zhang L, Yin HN, Hu YX, Zhao HR, et al. Surgery for young patients with lung cancer. Lung Cancer 2003; 42: 215-220.
22. Chen EG, Gao QQ, Ying KJ, Zhao C. Comparison between young and old patients with lung cancer. Chin J Cancer Res (Chin) 2002; 14: 305-308.
23. Kuo CW, Chen YM, Chao JY, Tsai CM, Perng RP. Non-small cell lung cancer in very young and very old patients. Chest 2000; 117: 354-357.
24. Butler CA, Darragh KM, Currie GP, Anderson WJ. Variation in lung cancer survival rates between countries: Do differences in data reporting contribute? Respir Med 2006; 100: 1642-1646.
25. Kreuzer M, Kreienbrock L, Gerken M, Heinrich J, Bruske-Hohlfeld I, Muller KM, et al. Risk factors for lung cancer in young adults. Am J Epidemiol 1998; 147: 1028-1037.
26. Kreuzer M, Kreienbrock L, Muller KM, Gerken M, Wichmann E. Histologic types of lung carcinoma and age at onset. Cancer 1999; 85: 1958-1965.
27. Shimosato Y Histological typing of lung and pleural tumors (3rd edition, 1999): Malignant epithelial tumors. Nippon Rinsho 2002; 60 Suppl 5: 123-131.
28. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-1717.
29. Mnami H, Yoshimura M, Miyamoto Y, Matsuoka H, Tsubota N. Lung cancer in women: Sex-associated differences in survival of patients undergoing resection for lung cancer. Chest 2000; 118: 1603-1609.
30. Jemal A, Travis WD, Tarone RE, Travis L, Devesa SS. Lung cancer rates convergence in young men and women in the United States: Analysis by birth cohort and histologic type. Int J Cancer 2003; 105: 101-107.
31. Belani CP, Marts S, Schiller J, Socinski MA. Women and lung cancer: Epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer 2007; 55: 15-23.
32. Jemal A, Ward E, Thun MJ. Contemporary lung cancer trends among U.S. women. Cancer Epidemiol Biomarkers Prev 2005; 14: 582-585.
33. Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005; 117: 294-299.
34. Bourke W, Milstein D, Giura R, Donghi M, Luisetti M, Rubin AH, et al. Lung cancer in young adults. Chest 1992; 102: 1723-1729.
35. Ramalingam S, Pawlish K, Gadgeel S, Demers R, Kalemkerian GP Lung cancer in young patients: Analysis of a surveillance, epidemiology, and end results database. J Clin Oncol 1998; 16: 651-657.
36. Mauri D, Pentheroudakis G, Bafaloukos D, Pectasides D, Samantas E, Efstathiou E, et al. Non-small cell lung cancer in the young: A retrospective analysis of diagnosis, management and outcome data. Anticancer Res 2006; 26: 3175-3181.
37. Sekine I, Nishiwaki Y, Yokose T, Nagai K, Suzuki K, Kodama T. Young lung cancer patients in Japan: Different characteristics between the sexes. Ann Thorac Surg 1999; 67: 1451-1455.
38. Zhang J, Chen SF, Zhen Y, Xiang JQ, Wu CX, Bao PP, et al. Multicenter analysis of lung cancer patients younger than 45 years in Shanghai. Cancer 2010; 116: 3656-3662.
39. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008; 452: 633-637.
40. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest 2003; 123 (1 Suppl): 21S-49S.
41. Etzel CJ, Amos CI, Spitz MR. Risk for smoking-related cancer among relatives of lung cancer patients. Cancer Res 2003; 63: 8531-8535.
42. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a different disease. Nat Rev Cancer 2007; 7: 778-790.
43. Miller VA, Hirsch FR, Johnson DH. Systemic therapy of advanced bronchioloalveolar cell carcinoma: Challenges and opportunities. J Clin Oncol 2005; 23: 3288-3293.
44. Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 2004; 126: 347-351.
45. Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, et al. Lung cancer incidence in never smokers. J Clin Oncol 2007; 25: 472-478.
46. Bryant A, Cerfolio RJ. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest 2007; 132: 185-192.
47. Jemal A, Cokkinides VE, Shafey O, Thun MJ. Lung cancer trends in young adults: An early indicator of progress in tobacco control (United States). Cancer Causes Control 2003; 14: 579-585.
48. Strand TE, Malayeri C, Eskonsipo PK, Grimsrud TK, Norstein J, Grotmol T Adolescent smoking and trends in lung cancer incidence among young adults in Norway 1954-1998. Cancer Causes Control 2004; 15: 27-33.
49. Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 2005; 93: 825-833.
50. Nitadori J, Inoue M, Iwasaki M, Otani T, Sasazuki S, Nagai K, et al. Association between lung cancer incidence and family history of lung cancer: Data from a large-scale population-based cohort study, the JPHC study. Chest 2006; 130: 968-975.
51. Ganti AK, Loberiza FR, Kessinger A. Association of positive family history with survival of patients with lung cancer. Lung Cancer 2009; 63: 136-139.
52. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GLOD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
53. Peces-Barba G, Barbera JA, Agusti A, Casanova C, Casas A, Izquierdo JL, et al. Diagnosis and management of chronic obstructive pulmonary disease: Joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT). Arch Bronconeumol 2008; 44: 271-281.
54. Papi A, Casoni G, Caramori G, Guzzinati I, Boschetto P, Ravenna F, et al. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax 2004; 59: 679-681.
55. Engels EA, Shen M, Chapman RS, Pfeiffer RM, Yu YY, He X, et al. Tuberculosis and subsequent risk of lung cancer in xuanwei, China. Int J Cancer 2009; 124: 1183-1187.
56. Ballaz S, Mulshine JL. The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 2003; 5: 46-62.
57. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
58. Engels EA. Inflammation in the development of lung cancer: Epidemiological evidence. Expert Rev Anticancer Ther 2008; 8: 605-615.
59. Choudhury AB, Dawson CM, Kilvington HE, Eldridge S, James WY, Wedzicha JA, et al. Withdrawal of inhaled corticosteroids in people with COPD in primary care: A randomised controlled trial. Respir Res 2007; 8: 93.
60. Abal Arca J, Parente Lamelas I, Almazan Ortega R, Blanco Pérez J, Toubes Navarro ME, Marcos Velázquez P. Lung cancer and COPD: A common combination. Arch Bronconeumol 2009; 45: 502-507.
61. De Cos JS, Miravet L, Abal J, Núñez A, Muñoz FJ, García L, et al. Lung cancer survival in Spain and prognostic factors: A prospective, multiregional study. Lung Cancer 2008; 59: 246-254.
62. Rauscher GH, Mayne ST, Janerich DT. Relation between body mass index and lung cancer risk in men and women never and former smokers. Am J Epidemiol 2000; 152: 506-513.
63. Kabat GC, Miller AB, Rohan TE. Body mass index and lung cancer risk in women. Epidemiology 2007; 18: 607-612.
64. Koh WP, Yuan JM, Wang R, Lee HP, Yu MC. Body mass index and smoking-related lung cancer risk in the Singapore Chinese health study. Br J Cancer 2010; 102: 610-614.
65. Kabat GC, Kim M, Hunt JR, Chlebowski RT, Rohan TE. Body mass index and waist circumference in relation to lung cancer risk in the women's health initiative. Am J Epidemiol 2008; 168: 158-169.
66. Yang P, Bamlet WR, Ebbert JO, Taylor WR, De Andrade M. Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis 2004; 25: 1935-1944.
67. Antkowiak JG, Regal AM, Takita H. Bronchogenic carcinoma in patients under age 40. Ann Thorac Surg 1989; 47: 391-393.
68. Ferguson MK, Skosey C, Hoffman PC, Golomb HM. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol 1990; 8: 1402-1407.
69. Gadgeel SM, Ramalingam S, Cummings G, Kraut MJ, Wozniak AJ, Gaspar LE, et al. Lung cancer in patients <50 years of age: The experience of an academic multidisciplinary program. Chest 1999; 115: 1232-1236.
70. Makitaro R, Paakko P, Huhti E, Bloigu R, Kinnula VL. An epidemiological study of lung cancer: History and histological types in a general population in northern Finland. Eur Respir J 1999; 13: 436-440.
71. Asmis TR, Ding K, Seymour L, Shepherd FA, Leighl NB, Winton TL, et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: A review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 2008; 26: 54-59.
72. Janssen-Heijnen ML, Smulders S, Lemmens VE, Smeenk FW, van Geffen HJ, Coebergh JW. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 2004; 59: 602-607.